Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESLICARBAZEPINE Cause Intentional product misuse? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Intentional product misuse have been filed in association with ESLICARBAZEPINE (Eslicarbazepine Acetate). This represents 0.4% of all adverse event reports for ESLICARBAZEPINE.

12
Reports of Intentional product misuse with ESLICARBAZEPINE
0.4%
of all ESLICARBAZEPINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Intentional product misuse From ESLICARBAZEPINE?

Of the 12 reports, 3 (25.0%) required hospitalization, and 2 (16.7%) were considered life-threatening.

Is Intentional product misuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESLICARBAZEPINE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does ESLICARBAZEPINE Cause?

Seizure (852) Off label use (344) Drug ineffective (312) Hyponatraemia (247) Dizziness (211) Somnolence (169) Fatigue (134) Rash (118) Headache (115) Fall (93)

What Other Drugs Cause Intentional product misuse?

ETANERCEPT (3,992) PREGABALIN (3,731) BUDESONIDE\FORMOTEROL (3,399) ACETAMINOPHEN (2,924) ESOMEPRAZOLE (2,852) MINOXIDIL (2,418) TOFACITINIB (2,331) CINACALCET (2,092) QUETIAPINE (1,855) ALPRAZOLAM (1,709)

Which ESLICARBAZEPINE Alternatives Have Lower Intentional product misuse Risk?

ESLICARBAZEPINE vs ESMOLOL ESLICARBAZEPINE vs ESOMEPRAZOLE ESLICARBAZEPINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESLICARBAZEPINE vs ESOMEPRAZOLE\NAPROXEN ESLICARBAZEPINE vs ESTAZOLAM

Related Pages

ESLICARBAZEPINE Full Profile All Intentional product misuse Reports All Drugs Causing Intentional product misuse ESLICARBAZEPINE Demographics